title: Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes.
abstract: We evaluated the in vitro activity of fosfomycin against a total of 192 CTX-M beta-lactamase-producing Escherichia coli strains isolated in 70 Japanese clinical settings. Most of the isolates (96.4%) were found to be susceptible to fosfomycin. On the other hand, some of the resistant isolates were confirmed to harbor the novel transferable fosfomycin resistance determinants named FosA3 and FosC2, which efficaciously inactivate fosfomycin through glutathione S-transferase activity.
authors.affiliation: Department of Bacteriology II, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011, Japan. wachino@nih.go.jp
authors.forename: Jun-ichi
authors.initials: J
authors.lastname: Wachino
authors.forename: Kunikazu
authors.initials: K
authors.lastname: Yamane
authors.forename: Satowa
authors.initials: S
authors.lastname: Suzuki
authors.forename: Kouji
authors.initials: K
authors.lastname: Kimura
authors.forename: Yoshichika
authors.initials: Y
authors.lastname: Arakawa
mesh_terms: D000595:Amino Acid Sequence; D024881:Drug Resistance, Bacterial / Q000235:genetics; D004926:Escherichia coli / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics*; D029968:Escherichia coli Proteins / Q000737:chemistry / Q000235:genetics; D005578:Fosfomycin / Q000494:pharmacology*; D005982:Glutathione Transferase / Q000235:genetics; D007564:Japan; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D010957:Plasmids / Q000235:genetics*; D017386:Sequence Homology, Amino Acid; D001618:beta-Lactamases / Q000378:metabolism*
chemical_list: D029968:Escherichia coli Proteins; C000607929:FosA(3) protein, E coli; D005578:Fosfomycin; D005982:Glutathione Transferase; D001618:beta-Lactamases
references.citation: Antimicrob Agents Chemother. 2010 Jan;54(1):526-9
references.pmid: 19901089
references.citation: Antimicrob Agents Chemother. 2007 Sep;51(9):3354-60
references.pmid: 17548499
references.citation: J Am Chem Soc. 2002 Sep 18;124(37):11001-3
references.pmid: 12224946
references.citation: Antimicrob Agents Chemother. 1980 Aug;18(2):215-9
references.pmid: 7004337
references.citation: Biochemistry. 1997 Mar 18;36(11):3050-5
references.pmid: 9115979
references.citation: Int J Antimicrob Agents. 2010 Apr;35(4):333-7
references.pmid: 20071153
references.citation: Drugs. 2009 Oct 1;69(14):1879-901
references.pmid: 19747006
references.citation: PLoS Genet. 2008 Jul 25;4(7):e1000141
references.pmid: 18654632
references.citation: Lancet Infect Dis. 2010 Jan;10(1):43-50
references.pmid: 20129148
references.citation: Antimicrob Agents Chemother. 2003 Sep;47(9):2850-8
references.pmid: 12936984
references.citation: Biochemistry. 1999 Jun 8;38(23):7462-9
references.pmid: 10360943
references.citation: J Biol Chem. 2005 May 6;280(18):17786-91
references.pmid: 15741169